References
- Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331–4336
- Aksoy M. The history of β thalassemia in Turkey. Turk J Pediatr. 1991;33(3):195–197
- Aksoy M, Lekin EW, Maurant AE, Lehmann H. Blood groups, hemoglobins, and thalassemia in Southern Turkey and Eti Turks. Br Med J. 1958;2(5102):937–939
- Çavdar AO, Arcasoy A. The incidence of β-thalassemia and abnormal hemoglobins in Turkey. Acta Hematol. 1971;45(5):313–318
- Beksac MS, Gumruk F, Gurgey A, et al. Prenatal diagnosis of hemoglobinopathies in Hacettepe University, Turkey. Pediatr Hematol Oncol. 2011;28(1):51–55
- Akar N, Çavdar AO, Dessi E, et al. β-Thalassemia mutations in the Turkish population. J Med Genet. 1987;24(6):378–379
- Canatan D, Arcasoy A. Thalassemiada kemik iliği transplantasyonu. Ankara Ü Tıp Fak Mecmuası. 1993;46(2):173–186
- Başak AN, Ozçelik H, Ozer A, et al. The molecular basis of β-thalassemia in Turkey. Hum Genet. 1992;89(3):315–318
- Altay Ç. Abnormal hemoglobins in Turkey. Turk J Haematol. 2002;19(1):63–74
- Kahraman S, Karlikaya G, Sertyel S, et al. Clinical aspects of preimplantation genetic diagnosis for single gene disorders combined with HLA typing. Reprod Biomed Online. 2004;9(5):529–532
- Canatan D. The Thalassemia Center of Antalya State Hospital: 15 years of experience (1994 to 2008). J Pediatr Hematol Oncol. 2013;35(1):24–27
- Canatan D, Kose MR, Ustundağ M, et al. Hemoglobinopathy control program in Turkey. Community Genet. 2006;9(2):124–126
- Canatan D, Aydınok Y, Kılınç Y, et al. National Thalassemia Prevention Campaign: The Talotýr Project. Turk J Haematol. 2013;30(1):91–92
- Canatan D. Status of thalassemia and hemoglobinopathies in world and Turkey. Canatan D, Ed. Türkiye Klinikleri J Hem Onc Special Topics. 2010;3(1):1–4
- Ministry of Health of Turkey. Hemoglobinopathy Control Program. Canatan D, Ed. Türkiye Klinikleri J Hem Onc Special Topics. 2010;3(1):5–8
- Canatan D, Ozsancak A. A new donor system for the patients with thalassemia: “Blood mother and blood father”. Asian J Transfus Sci. 2010;4(2):109–111
- Modell B, Darlison M. Global epidemiyology of hemoglobin disorders and derived service indicators. Bull World Health Org. doi: 10247/BLT 06.036673.04/03/2008
- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775. doi: 10.1101/cshperspect.a011775
- Silvestroni E, Bianco I, Graziani B, et al. First premarital screening of thalassaemia carriers in intermediate schools in Latium. J Med Genet. 1978;15(3):202–207
- Ladis V, Karagiorga-Lagana M, Tsatra I, Chouliaras G. Thirty-year experience in preventing haemoglobinopathies in Greece: Achievements and potentials for optimisation. Eur J Haematol. 2013;90(4):313–322
- Kyrri AR, Kalogerou E, Loizidou D, et al. The changing epidemiology of β-thalassemia in the Greek-Cypriot population. Hemoglobin. 2013;37(5):435–443
- Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet. 1981;1(8216):369–371
- Bozkurt G. Results from the North Cyprus Thalassemia Prevention Program. Hemoglobin. 2007;31(2):257–264
- Kalaydjieva L, Eigel A, Horst J. The molecular basis of β thalassaemia in Bulgaria. J Med Genet. 1989;26(10):614–618
- Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(1):D1063–D1069
- Hardison RC, Chui DHK, Riemer CR, et al. Access to A Syllabus of Human Hemoglobin Variants (1996) via the world wide web. Hemoglobin. 1998;22(2):113–127
- Canatan D. Hemoglobinopathy prevention program in Turkey. Reprod Biomed Online. 2013;26(Suppl 1):S8. DOI: http://dx.doi.org/10.1016/S1472-6483(13)60027-9